Degenerative retinal diseases are a heterogeneous group of eye diseases that can eventually cause permanent visual loss. Currently, millions of patients worldwide suffer from degenerative retinal diseases (1). Damage to any type of retinal neuron results in irreversible changes, and therapeutic modalities that can reverse these degenerative processes have not been available. However, recent progress in stem cell research has provided emerging hope for visual restoration in degenerative retinal diseases using cellular therapeutic approaches. One representative example of such a possibility was provided by a recent study on the transplantation of retinal pigment epithelial (RPE) cells that were derived from embryonic stem cells (ESCs) (2). A similar trial is underway by a Japanese stem cell research group using induced pluripotent stem cells (iPSCs). Interestingly, both clinical studies target Stargardt's macular dystrophy and dry age-related macular degeneration, in which RPE cell loss is the major pathophysiology. Although the molecular mechanisms that underlie various degenerative retinal diseases vary, they share a common endpoint: the irreversible loss of photoreceptor cells. Therefore, the transplantation of photoreceptor cells is mandatory for visual restoration in most degenerative retinal diseases. Accordingly, developing strategies for the regeneration of photoreceptor cells has been a highlighted area of interest in ophthalmology and regenerative medicine. Studies have identified two major sources of stem cells for photoreceptors: pluripotent stem cells (e.g., ESCs and iPSCs) and tissue-specific stem cells in retinal tissue (3-9). Although the multipotential differentiation of pluripotent stem cells (ESCs or iPSCs) allows the possibility of specific differentiation into photoreceptor cells, little success have been reported in this area of research, mostly because of procedural difficulties and such risk factors as tumor formation and viral integration. On the other hand, the possibility that endogenous retinal stem cells can be used for retinal regeneration has been suggested by several lines of investigation using retinal injury models (3-7). However, unlike other types of well-defined tissue-specific stem cells in other organs in the body, identification of the cells responsible for the retinal regenerative process has been hampered by a lack of definitively identifying retinal stem cells. Therefore, the present review primarily focuses on current studies that are directed toward identifying endogenous retinal stem cells at the cellular level and recent progress in cellular therapeutic trials using these cells.
RETINAL DEGENERATIVE DISEASE AND SEARCH FOR RETINAL REGENERATION
Degenerative retinal diseases are a heterogeneous group of eye diseases that can eventually cause permanent visual loss. Currently, millions of patients worldwide suffer from degenerative retinal diseases (1) . Damage to any type of retinal neuron results in irreversible changes, and therapeutic modalities that can reverse these degenerative processes have not been available. However, recent progress in stem cell research has provided emerging hope for visual restoration in degenerative retinal diseases using cellular therapeutic approaches. One representative example of such a possibility was provided by a recent study on the transplantation of retinal pigment epithelial (RPE) cells that were derived from embryonic stem cells (ESCs) (2) . A similar trial is underway by a Japanese stem cell research group using induced pluripotent stem cells (iPSCs). Interestingly, both clinical studies target Stargardt's macular dystrophy and dry age-related macular degeneration, in which RPE cell loss is the major pathophysiology. Although the molecular mechanisms that underlie various degenerative retinal diseases vary, they share a common endpoint: the irreversible loss of photoreceptor cells. Therefore, the transplantation of photoreceptor cells is mandatory for visual restoration in most degenerative retinal diseases. Accordingly, developing strategies for the regeneration of photoreceptor cells has been a highlighted area of interest in ophthalmology and regenerative medicine. Studies have identified two major sources of stem cells for photoreceptors: pluripotent stem cells (e.g., ESCs and iPSCs) and tissue-specific stem cells in retinal tissue (3) (4) (5) (6) (7) (8) (9) . Although the multipotential differentiation of pluripotent stem cells (ESCs or iPSCs) allows the possibility of specific differentiation into photoreceptor cells, little success have been reported in this area of research, mostly because of procedural difficulties and such risk factors as tumor formation and viral integration. On the other hand, the possibility that endogenous retinal stem cells can be used for retinal regeneration has been suggested by several lines of investigation using retinal injury models (3-7). However, unlike other types of well-defined tissue-specific stem cells in other organs in the body, identification of the cells responsible for the retinal regenerative process has been hampered by a lack of definitively identifying retinal stem cells. Therefore, the present review primarily focuses on current studies that are directed toward identifying endogenous retinal stem cells at the cellular level and recent progress in cellular therapeutic trials using these cells.
THE RETINA AND ENDOGENOUS STEM CELLS
The retina is composed of nine different neural or glial cells in a highly coordinated manner (Fig. 1) . Because of such a sophisticated structure, especially in adult mammals, traditional studies have failed to identify any regenerative potential in the retina after various types of retinal injury. However, further in-depth studies that utilized retinal injury models indicated that cells can differentiate into multiple types of retinal cells in Invited Mini Review http://bmbreports.org the injured retina. Therefore, regeneration of the retina is now becoming an emerging possibility. These endogenous stem cells in the retina include Muller glial cells and ciliary pigment epithelial (CPE) cells, which were identified using injury models of the retina in fish and amphibians. These cells exhibited the potential for retinal regeneration and multi-lineage differentiation, suggesting the possibility that photoreceptor cells derived from these cells may be utilized for transplantation like the clinical transplantation of full-thickness cornea or limbal stem cells. In the present paper, emphasis is placed on the proliferative potential and differentiation potential of several candidate stem cells that are derived from the adult mammalian eye, especially human eye, and the potential of photoreceptor replacement therapy for degenerative retinal diseases. (4). Additionally, they showed that Muller glial cells can differentiate into photoreceptor cells when cultured on basement membrane protein in the presence of FGF2, taurine, retinoic acid, and insulin-like growth factor-1, and these cells expressed photoreceptor markers, such as Crx, nuclear receptor subfamily 2, group E, member 3 (NR2E3), rhodopsin, and recoverin (7).
CELLULAR IDENTITY OF RETINAL STEM CELLS
Notably, the same study demonstrated the therapeutic potential of Muller glial cells to recover retinal function in a retinal disease model (i.e., when Muller glial cell-derived photoreceptor cells were transplanted into the retina in 3-week-old P23H rats, a model of retinitis pigmentosa). The transplanted cells exhibited migration and integration into the outer nuclear layer of the degenerated retinas, leading to improvement in rod photoreceptor function, reflected by an increase in the a-wave amplitude and slope using scotopic flash electroretinography (7 No rod photoreceptor cells were evident after 2 weeks of differentiation using any previously reported protocol (34). They found that CPE cells were reversed toward the epithelial phenotype when cultured in a retinal differentiation medium and did not differentiate into photoreceptors. Similarly, they found that the transduction of any single transcription factor gene or multiple transcription factors also failed to generate Nrl-GFP-positive cells. These findings were consistent with data reported by Cicero et al., in which no rod cell markers were detected after 3 weeks of differentiation with retinoic acid and taurine (33).
The reason for this discrepancy is not yet clear. However, it could be based on the detection method, and the duration of culture for differentiation into photoreceptors could also be a factor, especially considering that the developmental maturation of rod photoreceptor cells occurs at very late stages of development compared with other retinal cell types. Similarly, the process for ESCs or iPSCs to differentiate into mature rod photoreceptor cells requires a differentiation period of up to 180 days (38, 39). However, findings of the expression of immature cell markers of spheroid CPE cells with a failure to produce mature rod photoreceptor cells have been common across studies, indicating a limitation in their potential to differentiate into retinal stem cells. Additionally, the in vivo integration and differentiation observed in NOD/SCID mice also needs to be examined further because the findings were limited to postnatal day 1 NOD/SCID mice, and such results were not evident in an adult dystrophic RCS model. Similarly, additional studies on transplanted cells that migrate to and are integrated in the retina are warranted to examine their integrated function in the retina. Collectively, human CPE cells can express a certain range of retinal progenitor markers in spheroid form but appear to have limited potential for retinal neuronal differentiation and self-renewal. However, further studies are needed to determine whether these cells can differentiate into retinal neurons using alternative methods or longer periods of differentiation. As observed in other types of retinal progenitor cells, RPE cells that are cultured on a spheroid form tend to exhibit a higher stem cell phenotype. Salero et al. reported that a subgroup of RPE cells was activated into multipotent stem cells with the capacity of self-renewal and differentiation into RPE progeny or neural, osteo, chondro, or adipo-lineage mesenchymal progeny (45). In their report, similar to CPE cells, RPE cells grew more successfully when plated under adherent conditions than under suspension conditions. They found that cultured RPE cells under adherent conditions expressed the early eyefield and forebrain marker Pax6 and RPE marker MITF, but the retinal progenitor markers CHX10 and rhodopsin were not detected. In contrast, when cultured in suspension, a clonal line of RPE cells can produce RPE, adipocyte, chondrocyte, and bone lineage progeny. Because these studies focused on the transition of RPE cells to mesenchymal progeny, photoreceptor cell fate was not examined. Nonetheless, they showed that RPE spheres expressed early eyefield and forebrain markers, thus demonstrating the possibility of differentiating into retinal neurons. (7) n/a n/a *Clonality was confirmed by limiting dilution assay and secondary sphere formation assay. photoreceptor markers when engineered to express neuroD or ngn1 (46). Although the differentiation potential of RPE cells into photoreceptor cells has not been fully explored, relatively easy acquisition and culture in vitro highlight the possibility of using RPE cells as a source for transplantation in degenerative retinal degeneration.
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SUMMARY AND FUTURE DIRECTIONS
Therapeutic approaches to retinal regeneration are highly warranted. The direct differentiation of pluripotent stem cells, such as ESCs and iPSCs, constitutes one promising approach, but many issues need to be resolved before they can be applied in clinical-grade cell therapy, including biological risk and technical difficulties associated with differentiation culture procedures. The use of endogenous retinal stem cells is another promising approach, in which cell therapy for retinal disease and targeting their microenvironment to trigger their own regenerative potential can be developed. However, more studies are needed to elucidate the precise cellular identity of retinal stem cells that are responsible for retinal regeneration (Table 1) . Moreover, the cellular phenomena that underlie retinal regeneration require further in-depth examination because changes in cell fate can be induced, making interpretations of data on retinal differentiation and histological integration in the retina difficult. 
